Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
about
Treatment for paraneoplastic neuropathiesThe Production Processes and Biological Effects of Intravenous ImmunoglobulinParaneoplastic neurological complications of breast cancer.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Sensory neuronopathies.Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.Spontaneous neurological improvement in anti-Hu associated encephalomyelitisExpanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Paraneoplastic syndromes associated with lung cancerMyasthenia gravis-like syndrome presenting as a component of the paraneoplastic syndrome of lung adenocarcinoma in a nonsmokerGuidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Progress in the management of paraneoplastic neurological disorders.Intravenous immunoglobulin in neurological disease: a specialist review.Update on paraneoplastic neurologic disordersCarcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes.Immunomodulatory treatment trial for paraneoplastic neurological disorders.Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.Immunotherapy for paraneoplastic neurological disorders.Paraneoplastic syndromes of the CNS.Clinical applications of intravenous immunoglobulins in neurology.Successful Treatment with Methylnaltrexone and IVIG for Paraneoplastic Syndrome-Associated Intestinal Pseudo-Obstruction.CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model.Incidence and spectrum of paraneoplastic neurological syndromes: single center study.Paraneoplastic cerebellar degeneration in Hodgkin's lymphoma.Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: A beneficial antitumor immune response going awryIntravenous immunoglobulin treatment in chronic neurological diseases: do we have maintenance dose right?Treatment of paraneoplastic cerebellar degeneration.Paraneoplastic neurological syndromes: general treatment overview.Treatment of Cerebellar Ataxia in the Context of Systemic Diseases.Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.Treatment options in paraneoplastic disorders of the peripheral nervous system.7th International Immunoglobulin Conference: Interlaken Leadership Awards.Sensory Neuronopathies
P2860
Q24202148-FB2E9374-C835-4D79-AA6B-0DCC8F26EE0AQ26752540-CC5B5508-114F-45AB-8ADF-D4EA61EB14ACQ28077708-CAAD4C1F-499B-4EB8-8048-5251F915C675Q30276550-D4669E79-4743-43F1-B7D3-80E1E57BDC6BQ30278525-2BE144F7-3A36-4730-A435-8F8AAB1B50EBQ30587642-9C3ECBAE-7F03-4AD6-9F81-4188089AD4B4Q33714991-A1A26DD8-D330-4722-A13B-D8A1737F3FD6Q33770508-58A4A552-3003-40CB-9F8D-69F6B9D1C6D0Q34023610-CBDCA718-C252-468A-9AAA-C1A9681CB90DQ34032709-4C246A5A-0923-4E41-BE58-00EB26E8DC5DQ34122035-2A9CCD6E-708A-49FE-ADF0-19D4004D5F6AQ34409292-A0C5AE39-35C7-4731-B8AE-FC08510FC8A9Q34574581-D4075522-886C-4770-85C3-D5C225AB0C90Q34975086-D1F18CFC-B22C-4C26-A9A4-63CF7E1BC52DQ35451934-E8A0BF0B-65AA-4896-9D67-47B83AC83FD3Q35456681-C4784098-B99D-4B92-8CE5-2E70350B229CQ35788731-7F1FC656-6EF2-4B4E-88C6-C5AA67FD38DBQ35800688-880361B7-8533-41A6-87AA-3955843FE636Q35875642-42E222F9-7290-423C-A72E-C9F67491D0B4Q36273401-C1AD3D46-5286-443B-92EE-6682B1D3EA97Q36631871-A4587219-D20E-495F-8AFB-CB80F05A38C5Q37626126-B81E9A7F-5011-4F28-9CD2-82349DE517D3Q38618026-7D78B8B9-0B86-487A-A8B0-8FE18AD4BE5CQ38710453-9D240C23-6E9F-4BC4-82CF-39495D7B7DBCQ40607170-45953E7C-9489-4A8D-8EE4-D504C071B935Q41911075-53942C48-B4F9-43C7-96F9-8570A410FA90Q42610971-B45DC16D-F039-46B5-AB43-159BE12AC8A1Q43087483-1B7816B7-5F73-4B20-8F66-70AA3F23B24CQ44410712-57B88439-294D-4419-854B-DC946793EFCAQ44922918-9F5F6E11-6F55-408C-A581-D4D0D8322953Q47159668-FE96CB10-AF09-41C6-A477-623DB3A02879Q48101286-410771B0-9616-4719-A1F3-A9A77A7F1FB3Q51838886-EE9C1F53-230E-4A93-B9DE-F14FD55B703CQ54299706-3F3B4D5A-6508-4A0B-BB79-B6B42EC5B90FQ56501694-7BFB5E45-B855-44D8-9BF6-0470CB8D14A7
P2860
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Intravenous immunoglobulin tre ...... h antineuronal autoantibodies.
@ast
Intravenous immunoglobulin tre ...... h antineuronal autoantibodies.
@en
type
label
Intravenous immunoglobulin tre ...... h antineuronal autoantibodies.
@ast
Intravenous immunoglobulin tre ...... h antineuronal autoantibodies.
@en
prefLabel
Intravenous immunoglobulin tre ...... h antineuronal autoantibodies.
@ast
Intravenous immunoglobulin tre ...... h antineuronal autoantibodies.
@en
P2093
P2860
P356
P1476
Intravenous immunoglobulin tre ...... h antineuronal autoantibodies.
@en
P2093
P2860
P304
P356
10.1136/JNNP.60.4.388
P407
P577
1996-04-01T00:00:00Z